University Of Southern California
Clinical trials sponsored by University Of Southern California, explained in plain language.
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis early-stage trial tests a new drug called sEphB4-HSA alongside standard chemotherapy in people with advanced or metastatic solid tumors (like head and neck, pancreatic, lung, and gallbladder cancers). The main goals are to find the best dose and check for side effects. About…
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Virus-Enhanced cocktail takes on tough myeloma
Disease control OngoingThis early-phase study tests a combination of standard chemotherapy (bortezomib, dexamethasone), an immunotherapy (pembrolizumab), and a lab-modified virus (pelareorep) in people whose multiple myeloma has returned or stopped responding to prior treatments. The goal is to see if …
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Could a blood treatment keep hernias away after surgery?
Disease control OngoingThis study tests whether applying platelet-rich plasma (PRP) to the mesh used in hiatal hernia repair can lower the chance of the hernia returning. About 150 adults with large hiatal hernias will be randomly assigned to get either standard mesh repair or mesh plus PRP. The main g…
Phase: NA • Sponsor: University of Southern California • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Engineered immune cells take on Hard-to-Treat breast cancer
Disease control TerminatedThis early-stage trial tests a personalized cell therapy for people with advanced triple negative breast cancer that has stopped responding to standard treatments. Researchers take a patient's own immune cells, modify them in the lab to recognize a protein called NY-ESO-1 found o…
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Gum recession surgery showdown: which technique wins?
Disease control TerminatedThis study planned to compare four surgical techniques for treating receding gums, including flap surgery and tunneling methods, with or without a platelet-rich fibrin concentrate. It aimed to see which approach best covers exposed tooth roots and improves gum attachment. The tri…
Phase: NA • Sponsor: University of Southern California • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New hope for tough prostate cancer: drug combo targets bone tumors
Disease control OngoingThis study looks at how well the drug enzalutamide works alone or with a radiation drug called radium-223 in men with advanced prostate cancer that has spread to bones. The goal is to see if the combination can better control the cancer by boosting the immune system and shrinking…
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Could a two-drug combo slow kidney cancer better than one?
Disease control OngoingThis study tests whether adding an experimental immune-boosting drug (anti-OX40 antibody) to the standard targeted therapy axitinib helps control advanced kidney cancer better than axitinib alone. About 62 adults whose cancer worsened after prior immunotherapy will receive either…
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Can a common antibiotic beat syphilis?
Disease control OngoingThis study tests whether the antibiotic linezolid can effectively treat early syphilis. About 24 adults with primary, secondary, or early latent syphilis will receive linezolid, and researchers will check if their blood test levels drop enough by 6 months. The goal is to find a n…
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
New drug combo targets tough cancers: hope for liver, pancreas, and bile duct tumors
Disease control OngoingThis early-phase study tests a combination of two drugs, guadecitabine and durvalumab, in people with advanced liver, pancreatic, bile duct, or gallbladder cancer that has spread. The main goals are to find the safest dose and see if the drugs can shrink tumors. About 55 particip…
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New drug combo shows promise against tough leukemia
Disease control OngoingThis study tests a new drug called pevonedistat alongside standard chemotherapy (cytarabine and idarubicin) in people newly diagnosed with high-risk acute myeloid leukemia (AML). The goal is to find the best dose and see if the combination improves the chance of complete remissio…
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New drug combo targets tough blood cancers
Disease control OngoingThis study tests a combination of two drugs, guadecitabine and atezolizumab, in adults with myelodysplastic syndrome or chronic myelomonocytic leukemia that has spread, returned, or not responded to prior treatment. The goal is to find the best dose and see how well the drugs wor…
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
New combo therapy aims to turn tumors against themselves in advanced cancer patients
Disease control OngoingThis early-phase study tests whether a mix of drugs and targeted radiation can help the immune system recognize and attack hard-to-treat solid tumors. About 14 adults with advanced melanoma, breast cancer, or other solid cancers that cannot be surgically removed will receive inje…
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New test could spot kidney cancer early using blood and urine
Diagnosis OngoingThis study looks at whether measuring certain immune cells (MDSCs) in blood and urine can help detect kidney cancer early and monitor how it responds to treatment. Researchers will compare MDSC levels in healthy volunteers, patients with early-stage kidney cancer, and those with …
Sponsor: University of Southern California • Aim: Diagnosis
Last updated May 15, 2026 11:55 UTC
-
Dinner table therapy: monthly meals aim to cure med student burnout
Symptom relief OngoingThis study tests whether monthly group meals with guided conversation can reduce burnout and loneliness in medical students. About 80 students in their clinical years will be assigned to small groups that meet for six months. The goal is to see if this simple, social approach imp…
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
New study tests sleep aids for ICU confusion
Symptom relief TerminatedThis study aimed to see if trazodone, a sleep medication, works better than quetiapine or a placebo for treating confusion (delirium) in adult surgical ICU patients. Researchers planned to measure how long delirium lasted, sleep quality, and side effects. However, the study was w…
Phase: PHASE4 • Sponsor: University of Southern California • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
Online therapy showdown: CBT vs ACT for depression
Symptom relief OngoingThis study compares two well-known psychological treatments for depression: cognitive-behavioral therapy (CBT) and acceptance and commitment therapy (ACT). Up to 100 adults with major depressive disorder will receive 8 weeks of online group therapy via Zoom. The goal is to see wh…
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC
-
Virtual reality may ease pain for cancer patients during needle procedures
Symptom relief TerminatedThis study looks at whether using virtual reality (VR) can help reduce pain and anxiety in cancer patients who are getting a bone marrow biopsy or a lumbar puncture. About 60 participants will use VR during the procedure and report their pain and anxiety levels. The goal is to se…
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated May 14, 2026 12:01 UTC
-
Can fasting before immunotherapy reduce side effects? new study investigates
Symptom relief OngoingThis early-stage study looks at whether short-term fasting (eating less than 200 calories per day for 3 days before each treatment) is safe and doable for people with advanced or metastatic skin cancer who are receiving standard immunotherapy drugs like pembrolizumab or nivolumab…
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Symptom relief
Last updated May 12, 2026 13:43 UTC
-
New study tests better ways to help kids with cerebral palsy sit and reach
Symptom relief OngoingThis study compares two physical therapy approaches for children aged 8-24 months with or at high risk for cerebral palsy. One method focuses on sitting, reaching, and problem-solving, while the other targets general motor skills. The goal is to see which therapy improves sitting…
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated May 11, 2026 20:51 UTC
-
Diet before chemo may cut side effects in cancer patients
Symptom relief OngoingThis study tests whether eating a low-calorie diet before chemotherapy can reduce side effects like fatigue, nausea, and mouth sores, and also improve how well the treatment works. About 130 adults with breast or prostate cancer will follow either a controlled low-calorie diet or…
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated May 11, 2026 20:50 UTC
-
Leg amputation wound therapy study pulled before it started
Knowledge-focused TerminatedThis study planned to test a special vacuum dressing on the surgical wound after a leg amputation, comparing it to standard bandages. The goal was to see if it reduced swelling, helped people walk sooner, and was more comfortable. However, the study was withdrawn before any parti…
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
New web tool aims to help sinusitis patients decide on surgery
Knowledge-focused ENROLLING_BY_INVITATIONThis study is testing a new bilingual web tool to help people with chronic sinusitis decide between surgery and other treatments. About 50 patients will use the tool or get standard information. The goal is to see if the tool helps patients make choices that match their personal …
Phase: NA • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC
-
Scientists hunt for genetic clues to prevent deadly clots after hip and knee surgery
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to find genetic markers that may increase the risk of a pulmonary embolism (a serious blood clot in the lung) after total hip or knee replacement surgery. Researchers will collect blood samples from 100 adults aged 18-70 who have had a pulmonary embolism after suc…
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated May 08, 2026 12:04 UTC
-
Massive Alzheimer's study tracks brain changes over time
Knowledge-focused ENROLLING_BY_INVITATIONThis long-term study follows 1,500 adults with normal memory, mild cognitive impairment, or Alzheimer's disease. Researchers use brain scans, memory tests, and genetic data to understand how the disease progresses and to improve future clinical trials. The study also aims to incl…
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated May 07, 2026 18:40 UTC
-
AI chatbot tested for brain tumor decisions – study pulled
Knowledge-focused TerminatedThis study aimed to see if using ChatGPT could help patients recently diagnosed with vestibular schwannoma (a non-cancerous brain tumor) feel less confused and more satisfied with their treatment choices. Researchers planned to compare decision-making scores between a group train…
Phase: NA • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Apr 24, 2026 16:17 UTC